Clinical and genetic features of 20 Japanese patients with vascular-type Ehlers-Danlos syndrome

British Journal of Dermatology

Volumn 163, Issue 4, 2010, Pages 704-710

  Shimaoka, Y ^a   Kosho, T ^b   Wataya Kaneda, M ^c   Funakoshi, M ^a   Suzuki, T ^a   Hayashi, S ^a   Mitsuhashi, Y ^d   Isei, T ^e   Aoki, Y ^f   Yamazaki, K ^f   Ono, M ^g   Makino, K ^h   Tanaka, T ⁱ   Kunii, E ^j   Hatamochi, A ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e KANSAI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^f TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Ono Dermatology Clinic   (Japan)

^h KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

ⁱ SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^j GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

more..

Author keywords

clinical findings; COL3A1; Ehlers Danlos syndrome (vascular type); mutations; type III collagen

Indexed keywords

COLLAGEN TYPE 3;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; EHLERS DANLOS SYNDROME; FEMALE; FIBROBLAST; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; JAPANESE; JOINT HYPERMOBILITY; MALE; PHENOTYPE; POINT MUTATION; PREVALENCE; PRIORITY JOURNAL; SKIN BRUISING;

ADOLESCENT; ADULT; CELLS, CULTURED; COLLAGEN TYPE III; DNA MUTATIONAL ANALYSIS; EHLERS-DANLOS SYNDROME; FEMALE; FIBROBLASTS; HUMANS; MALE; POINT MUTATION; SKIN; SKIN DISEASES, VASCULAR; YOUNG ADULT;

EID: 77957051504     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09874.x     Document Type: Article

References (20)

1. Beighton P, De Paepe A, Steinmann B et al. Ehlers-Danlos syndrome: revised nosology, Villefranche. J Med Genet 1998 77 : 31 7.
2. Pepin MG, Byers PH. Ehlers-Danlos syndrome, vascular type. 2006. Available from: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book= gene&part=eds4 (last accessed 27 May 2010).
3. Dalgleish R. The human collagen mutation database 1998. Nucleic Acids Res 1998 26 : 253 255.
4. De Paepe A, Malfait F. Bleeding and bruising in individuals with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol 2004 127 : 491 500.
5. Pope FM, Narcisi P, Nicholis AC et al. COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture. Br J Dermatol 1996 135 : 163 181.
6. Kuivaniemi H, Kontusaari S, Tromp G et al. Identical G+1 to A mutations in three different introns of the type III procollagen gene (COL3A1) produce different patterns of RNA splicing in three variants of Ehlers-Danlos syndrome. IV. An explanation for exon skipping some mutations and not others. J Biol Chem 1990 265 : 12067 12074.
7. Schwarze U, Goldstein JA, Byers PH. Splicing defects in the COL3A1 gene: marked preference for 5′ (donor) splice-site mutations in patient with exon-skipping mutations and Ehlers-Danlos syndrome type IV. Am J Hum Genet 1997 61 : 1276 1286.
8. Pepin M, Schwarze U, Superti-Furga A et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000 342 : 673 680.
9. Oderich GS, Pannecton JM, Bower NM et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg 2005 42 : 98 106.
10. Matsushita A, Takayanagi N, Ishiguro T et al. A case of Ehlers-Danlos syndrome suspected from pulmonary hematoma due to disruption of the lung. Nihon Kokyuki Gakkai Zasshi (Japanese edition) 2009 47 : 704 710.
11. Ishiguro T, Takayanagi N, Kawabata Y et al. Ehlers-Danlos syndrome with recurrent spontaneous pneumothoraces and cavitary lesion on chest X-ray as the initial complications. Intern Med 2009 48 : 717 722.
12. Sadakata R, Hatamochi A, Kodama K et al. A case of Ehlers-Danlos syndrome type IV, vascular type, demonstrated a newly recognized point mutation in the COL3A1 gene. Intern Med 2010 in press.
13. Omori H, Hatamochi A, Koike M et al. Sigmoid colon perforation induced by the vascular type of Ehlers-Danlos syndrome: report of a case. Surg Today 2010 in press.
14. Okita H, Ikeda Y, Mitsuhashi Y et al. A novel point mutation at donor splice-site in intron 42 of type III collagen gene resulting in the inclusion of 30 nucleotides into the mature mRNA in a case of vascular type of Ehlers-Danlos syndrome. Arch Dermatol Res 2010 302 : 395 399.
15. Fleischmajer R, Perlish JS, Krieg T et al. Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Dermatol 1981 76 : 400 403.
16. Hata R, Kurata S, Shinkai H. Existence of malfunctioning pro α2(I) collagen genes in a patient with a pro α2(I)-chain-defective variant of Ehlers-Danlos syndrome. Eur J Biochem 1988 174 : 231 237.
17. Hatamochi A, Ono M, Ueki H et al. Regulation of collagen gene expression by transformed human fibroblasts: decreased type I and type III collagen RNA transcription. J Invest Dermatol 1991 96 : 473 477.
18. Kuivaniemi H, Tromp G, Prockop DJ. Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels. Hum Mutat 1997 9 : 300 315.
19. Schwarze U, Schievink WI, Petty E et al. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV. Am J Hum Genet 2001 69 : 989 1001.
20. Watanabe A, Kosho T, Wada T et al. Genetic aspects of vascular type of Ehlers-Danlos syndrome (vEDS, EDSIV) in Japan. Circ J 2007 71 : 261 265.